Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes
Clinical trial NCT02811484 · WITHDRAWN
Trial details
- NCT number
- NCT02811484
- Sponsor
- Weill Medical College of Cornell University
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.